跳至主要内容
临床试验/CTRI/2010/091/002950
CTRI/2010/091/002950尚未招募4 期

A gamma scintigraphy study to compare the lung deposition and blood bioavailability of dry powder formulations for inhalation containing radiolabeled budesonide/formoterol (200/6mcg) in adult healthy volunteers

Glenmark Pharmaceuticals Ltd.,Glenmark House,HDO-Corporate Building,Wing-A, B.D. Sawant Marg, Chakala,Off Western Express Highway,Andheri (E) Mumbai 400099.0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Healthy male volunteers with age ranging from 18 to 45 years.
  • Non-smokers with deep inspiration capacity
  • Ability to master DPI inhalation technique in dummy experiments
  • Written informed consent by volunteers
  • Volunteers willing to follow up.

排除标准

  • Volunteers unable to inhale DPI properly and with consistency
  • Patients with known hypersensitivity to budesonide or formoterol, Technetium 99 m to compounds structurally related to the study drugs or to any other component included.
  • Heavy smokers or volunteers with underlying respiratory problems interfering with vital capacity or giving rise to PFT abnormality or inconsistency
  • Volunteers with osteoporosis or any condition predisposing to low bone density
  • Volunteers having any contraindication like asthma, COPD, past history of tuberculosis
  • Volunteers with out of normal range values in any of the following laboratory blood tests: complete blood count, blood glucose, ionogram, AST, ALT, total bilirrubin, total proteins, urea, creatinine, total cholesterol and triglycerides and urine potassium levels.
  • Any other condition that in the opinion of the investigator does not justify the patient?s participation in the study

研究者

发起方
Glenmark Pharmaceuticals Ltd.,Glenmark House,HDO-Corporate Building,Wing-A, B.D. Sawant Marg, Chakala,Off Western Express Highway,Andheri (E) Mumbai 400099.

相似试验